US59156R5046
US59156R5046
MetLife, Inc. Preferred Series
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | -- | 13.53B EUR | 13.39B EUR | 14.17B EUR |
Enterprise Value | 37B EUR | 15.57B EUR | 11.83B EUR | 12.32B EUR |
Valuation Multiples | ||||
Trailing P/E | 2.73x | 3.73x | 3.7x | 5.82x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | -- | 0.17x | 0.18x | 0.25x |
Price to Book | 0.49x | 0.49x | 0.49x | 0.5x |
EV/Revenue | 0.47x | 0.2x | 0.16x | 0.21x |
EV/EBITDA | 6.13x | -- | -- | -- |
Price to FCF (P/FCF) | -- | 0.87x | 0.86x | 1.1x |
EV/FCF | -- | 1x | 0.76x | 0.96x |
FCF Yield | -- | 115.02% | 115.92% | 90.55% |